Diallyl sulfide as a potential dietary agent to reduce TNF-α- and histamine-induced proinflammatory responses in A7r5 cells

Targeted Deletion of Jun/AP-1 in Alveolar Epithelial Cells Causes Progressive Emphysema and Worsens Cigarette Smoke–Induced Lung Inflammation

(2012) Narsa M. Reddy et al.   AMERICAN JOURNAL OF PATHOLOGY

Histamine may induce airway remodeling through release of epidermal growth factor receptor ligands from bronchial epithelial cells

(2012) Nobuaki Hirota et al.   FASEB JOURNAL

Anti-malarial drug artesunate ameliorates oxidative lung damage in experimental allergic asthma

(2012) Wanxing Eugene Ho et al.   FREE RADICAL BIOLOGY AND MEDICINE

Piclamilast inhibits the pro-apoptotic and anti-proliferative responses of A549 cells exposed to H2O2via mechanisms involving AP-1 activation

(2012) Manuel Mata et al.   FREE RADICAL RESEARCH

Protective effects of an extract from Citrus bergamia against inflammatory injury in interferon-gamma and histamine exposed human keratinocytes

(2012) Adriana C.E. Graziano et al.   LIFE SCIENCES

Loss of DJ-1 Does Not Affect Mitochondrial Respiration but Increases ROS Production and Mitochondrial Permeability Transition Pore Opening

(2012) Emilie Giaime et al.   PLoS One

Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways

(2011) Shimei Qi et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Effect of Diallyl Sulfide on in Vitro and in Vivo Nrf2-Mediated Pulmonic Antioxidant Enzyme Expression via Activation ERK/p38 Signaling Pathway

(2011) Cheng-Ying Ho et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Regulation of the immune response and inflammation by histamine and histamine receptors

(2011) Liam O’Mahony et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Antioxidant N-acetyl-L-cysteine (NAC) supplementation reduces reactive oxygen species (ROS)-mediated hepatocellular tumor promotion of indole-3-carbinol (I3C) in rats

(2011) Keisuke Shimamoto et al.   JOURNAL OF TOXICOLOGICAL SCIENCES

Plasma levels and skin-eosinophil-expression of vascular endothelial growth factor in patients with chronic urticaria

(2009) A. Tedeschi et al.   ALLERGY

Immunobiology of Asthma

(2009) Qutayba Hamid et al.   Annual Review of Physiology

Redox Control of Asthma: Molecular Mechanisms and Therapeutic Opportunities

(2009) Suzy A.A. Comhair et al.   ANTIOXIDANTS & REDOX SIGNALING

Epicatechin induces NF-κB, activator protein-1 (AP-1) and nuclear transcription factor erythroid 2p45-related factor-2 (Nrf2) via phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) and extracellular regulated kinase (ERK) signalling in HepG2 cells

(2009) Ana Belén Granado-Serrano et al.   BRITISH JOURNAL OF NUTRITION

Diallyl sulfide enhances antioxidants and inhibits inflammation through the activation of Nrf2 against gentamicin-induced nephrotoxicity in Wistar rats

(2009) Srinivasan Kalayarasan et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Garlic components inhibit angiotensin II-induced cell-cycle progression and migration: Involvement of cell-cycle inhibitor p27Kip1 and mitogen-activated protein kinase

(2009) Claudia Castro et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Oxidative and Nitrative Stress in Bronchial Asthma

(2008) Hisatoshi Sugiura et al.   ANTIOXIDANTS & REDOX SIGNALING

Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: Critical role of iNOS, NF-κB, TNF-α and IL-1β

(2008) Srinivasan Kalayarasan et al.   LIFE SCIENCES

Diallyl sulfide induces apoptosis in Colo 320 DM human colon cancer cells: involvement of caspase-3, NF-κB, and ERK-2

(2008) Narayanan Sriram et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Protective Effects of Diallyl Sulfide, a Garlic Constituent, on the Warm Hepatic Ischemia–Reperfusion Injury in a Rat Model

(2008) Imam H. Shaik et al.   PHARMACEUTICAL RESEARCH

Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2–Keap1 signaling

(2008) Narayanan Sriram et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Targeting TNF-α: A novel therapeutic approach for asthma

(2007) Christopher Brightling et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY